Lv11
50 积分 2022-06-21 加入
Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years
2小时前
已完结
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
6个月前
已完结
Microsatellite Instability Testing Using Next-Generation Sequencing Data and Therapy Implications
7个月前
已完结
Classification and characterization of microsatellite instability across 18 cancer types
10个月前
已完结
WRN Helicase: Is There More to MSI-H than Immunotherapy?
10个月前
已完结
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial
1年前
已完结
Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval
1年前
已完结
How a controversial US drug policy could be harming cancer patients worldwide
1年前
已完结
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial
2年前
已完结
皖公网安备34019202002308
